2004 - Fellow of the Royal Society of Edinburgh
David J. Webb spends much of his time researching Internal medicine, Endocrinology, Blood pressure, Anesthesia and Endothelin receptor. Internal medicine is closely attributed to Cardiology in his research. His study in Blood pressure is interdisciplinary in nature, drawing from both Surgery and Renal function.
His Anesthesia study combines topics from a wide range of disciplines, such as Omega-N-Methylarginine, Placebo, Crossover study and Blood flow. David J. Webb has included themes like Blood vessel, Blockade, Circulatory system and Endothelin 1 in his Endothelin receptor study. His research investigates the connection between Endothelium and topics such as Sodium nitroprusside that intersect with problems in Pharmacology.
His primary scientific interests are in Internal medicine, Endocrinology, Blood pressure, Endothelin receptor and Cardiology. His Internal medicine study is mostly concerned with Endothelin 1, Vasodilation, Vasoconstriction, Arterial stiffness and Endothelium. The concepts of his Endocrinology study are interwoven with issues in Endothelins and Forearm.
David J. Webb combines subjects such as Hemodynamics, Anesthesia and Placebo with his study of Blood pressure. His Endothelin receptor research is multidisciplinary, incorporating perspectives in Heart failure, Pharmacology and Antagonist, Receptor antagonist. His Cardiology research incorporates elements of Pulse wave velocity and Surgery.
David J. Webb mainly focuses on Internal medicine, Blood pressure, Endocrinology, Kidney disease and Endothelin receptor. His studies in Internal medicine integrate themes in fields like Diabetes mellitus and Cardiology. His Blood pressure research also works with subjects such as
His Endocrinology research integrates issues from Sitaxentan and Pulmonary hypertension. His studies deal with areas such as Endothelins, Bioinformatics, Endothelial dysfunction, Disease and Dialysis as well as Kidney disease. His study looks at the intersection of Endothelin receptor and topics like Pharmacology with Nitric oxide and Vasodilation.
The scientist’s investigation covers issues in Internal medicine, Blood pressure, Endocrinology, Kidney disease and Cardiology. His research in Internal medicine intersects with topics in Diabetes mellitus and Pathology. The various areas that David J. Webb examines in his Blood pressure study include Spironolactone, Placebo, Randomized controlled trial and Sitaxentan.
His studies in Endocrinology integrate themes in fields like PER1, CLOCK and PER2. His research integrates issues of Inflammation, Disease, Endothelin 1 and Renal function in his study of Kidney disease. His Cardiology study frequently draws connections to other fields, such as Endothelium.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Aortic pulse wave velocity improves cardiovascular event prediction: an individual participant meta-analysis of prospective observational data from 17,635 subjects
Yoav Ben-Shlomo;Melissa Spears;Chris Boustred;Margaret May.
Journal of the American College of Cardiology (2014)
The influence of heart rate on augmentation index and central arterial pressure in humans
Ian B. Wilkinson;Helen MacCallum;Laura Flint;John R. Cockcroft.
The Journal of Physiology (2000)
Reproducibility of pulse wave velocity and augmentation index measured by pulse wave analysis
Ian B. Wilkinson;Sabine A. Fuchs;Ilse M. Jansen;James C. Spratt.
Journal of Hypertension (1998)
Noninvasive Assessment of Arterial Stiffness and Risk of Atherosclerotic Events
James J. Oliver;David J. Webb.
Arteriosclerosis, Thrombosis, and Vascular Biology (2003)
Endothelial function and dysfunction. Part II: Association with cardiovascular risk factors and diseases. A statement by the Working Group on Endothelins and Endothelial Factors of the European Society of Hypertension
Hanspeter Brunner;John R. Cockcroft;John Deanfield;Ann Donald.
Journal of Hypertension (2005)
Endothelial function and dysfunction. Part I: Methodological issues for assessment in the different vascular beds: A statement by the working group on endothelin and endothelial factors of the European society of hypertension
John Deanfield;Ann Donald;Claudio Ferri;Cristina Giannattasio.
Journal of Hypertension (2005)
A high-fat meal induces low-grade endotoxemia: evidence of a novel mechanism of postprandial inflammation
Clett Erridge;Teresa Attina;Corinne M Spickett;David J Webb.
The American Journal of Clinical Nutrition (2007)
Contribution of endogenous generation of endothelin-1 to basal vascular tone
W.G Haynes;D.J Webb.
The Lancet (1994)
Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial
Bryan Williams;Thomas M MacDonald;Steve Morant;David J Webb.
The Lancet (2015)
Nitric Oxide Regulates Local Arterial Distensibility In Vivo
Ian B. Wilkinson;Ahmed Qasem;Carmel M. McEniery;David J. Webb.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: